GLP-1s: Pros, cons, and questions

For some people, GLP-1 drugs are genuinely life-changing. Not just for weight loss, but for blood sugar control, blood pressure, food noise, binge eating, and, for tirzepatide/Zepbound specifically, moderate-to-severe obstructive sleep apnea in adults with obesity. Some people feel like they’ve finally been released from decades of cravings and metabolic dysfunction.

But the same drug that feels miraculous for one person can be a disaster for another.

One person’s inflammation improves. Another can’t eat without nausea, loses muscle, gets gallbladder pain, or suddenly can’t sleep.

One person’s compulsive eating quiets down. Another feels flat, exhausted, and unlike themselves.

One person loses weight with minimal side effects. Another ends up at an ophthalmologist’s office.

GLP-1s are neither miracle drugs nor poison. They’re powerful metabolic and neurologic drugs with real upsides, risks, and a lot of unanswered questions. Right now, the public conversation is still far too one-sided.

Why GLP-1s Work

Because GLP-1 receptors are found in the brain, gut, pancreas, heart, blood vessels, and immune system, they can affect much more than body weight.

They can:

• reduce appetite and slow gastric emptying
• improve blood sugar control and insulin sensitivity
• quiet “food noise” and compulsive eating
• improve some cardiometabolic markers
• reduce reward-driven behaviors around food and even alcohol

That effect on reward circuitry is one reason these drugs are now being studied beyond diabetes and obesity. But it’s too early to talk about them as if they’re treatments for compulsive behavior.

GLP-1s and Autoimmunity

This is where the conversation gets more interesting.

GLP-1 receptors are present on immune cells, and GLP-1 signaling appears to influence inflammatory pathways. In some people, this may reduce inflammation, improve insulin resistance, and calm autoimmune symptoms. Weight loss itself can also reduce inflammation.

That helps explain why some patients with Hashimoto’s, inflammatory arthritis, or other autoimmune conditions report feeling better on these drugs.

But the immune system is highly complex and individualized. There are also case reports of new-onset autoimmune problems during GLP-1 treatment, including alopecia areata, psoriasis, and inflammatory arthritis.

This means they should not be framed as uniformly helpful for autoimmunity.

The Side Effects That Actually Make People Quit

A lot of GLP-1 discussions focus on rare catastrophic risks and skip the side effects that make patients stop. For many people, the problem isn’t pancreatitis or blindness. It’s that they simply cannot function well on the drug.

1) GI slowdown that becomes intolerable: GLP-1s slow gastric emptying, which can mean constant nausea, reflux, sulfur burps, bloating, vomiting, or constipation severe enough to need laxatives or enemas. As a result, some patients cannot eat enough protein, calories, or fluids to function well.

2) Gallbladder attacks and biliary problems: GLP-1 drugs are associated with increased gallbladder and biliary disease, including gallstones and cholecystitis. Some of that may be from rapid weight loss itself.

3) Loss of lean mass: Weight loss on these drugs includes lean mass. If a patient is not eating enough protein nor doing resistance training, they can become smaller on paper but weaker in real life. For midlife and older adults, especially women, this is especially critical.

4) Fatigue, malaise, and “I don’t feel like myself:” Some people feel weak, cold, tired, mentally dull, or exercise-intolerant for months until stopping. Sometimes that’s from under-eating, dehydration, poor sleep, or loss of lean mass. Sometimes it’s just poor tolerance.

5) Insomnia

Insomnia is a labeled GLP-1 side effect, but is reported often enough in online forums to mention. People describe difficulty falling asleep, waking after a few hours, or feeling neurologically wired despite being exhausted. Sleep is foundational to all aspects of health, including brain health. If you can’t sleep on a GLP-1, it’s not worth it.

The Vision Risk That Deserves More Attention

In 2024, researchers reported an association between semaglutide and reduced blood flow to the optic nerve that can cause sudden vision loss.

Higher-risk patients include those with diabetes, vascular disease, obstructive sleep apnea, smoking history, or a structurally crowded optic disc.

The Bottom Line

If you’re on a GLP-1 drug and doing well, it’s a reasonable choice. But “doing well” should also mean you can eat enough protein, preserve muscle, sleep normally, and feel like yourself.

But they can alter appetite, digestion, blood sugar, reward signaling, and immune and vascular pathways in a way that doesn’t work for everyone.

The question is not whether GLP-1s are good or bad, but whether they support you or sabotage you.